Regenicin, Inc. (RGIN)
Grows lab-made skin to treat burns and chronic wounds.
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
RGIN is trading at its 52-week low with a heavily bearish analyst lean (21/100 score). The stock shows mixed momentum against its moving averages, and coverage appears minimal or absent. Current price action offers no clear directional signal.
What’s behind the score
Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$15,348
52-wk high
$0.75
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—